49 results
10-K
2024 FY
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
addressed to the FDA’s satisfaction in a resubmission of the NDA, the FDA will issue an approval letter. The FDA has committed to reviewing … or comparable international regulatory authorities’ satisfaction before any product is approved and our commercial products can be manufactured. We rely
10-K
2024 FY
EX-4.2
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
of the Company the amount of such tax, if any, or shall have established to the reasonable satisfaction of the Company and the Warrant Agent that such tax … the Warrant Agent receives written instructions signed by the Company which eliminates such ambiguity or uncertainty to the satisfaction of Warrant Agent.
(m
8-K
EX-10.2
IXHL
Incannex Healthcare Limited
10 Sep 24
Entry into a Material Definitive Agreement
7:30am
to consummate the Second Closing shall be contingent on the satisfaction of the following additional conditions, unless the Company and the Requisite … Closing to consummate the First Closing is subject to the satisfaction on or before the First Closing Date of each of the following conditions, any
8-K
IXHL
Incannex Healthcare Limited
10 Sep 24
Entry into a Material Definitive Agreement
7:30am
by the Company of the equity line of credit, is subject to the satisfaction of customary closing conditions.
Securities Purchase Agreement … .
The closing of each tranche of the Notes is subject to the satisfaction of customary closing conditions.
Item 9.01 Financial Statements and Exhibits
8-K
EX-10.1
IXHL
Incannex Healthcare Limited
10 Sep 24
Entry into a Material Definitive Agreement
7:30am
.
“Company Indemnitees” shall have the meaning set forth in Section 5.02.
“Condition Satisfaction Date” shall have the meaning set forth in Section 7.01 … transaction or otherwise) Common Shares to deliver in satisfaction of a sale by Investor of Common Shares submitted for legend removal by Investor
S-1/A
EX-5.1
jm08fe2rnly48
17 Jul 24
IPO registration (amended)
8:47am
S-1/A
EX-10.10
de6fng77w 1h
17 Jul 24
IPO registration (amended)
8:47am
S-1/A
f2gbfkqtzd2roo
17 Jul 24
IPO registration (amended)
8:47am
S-1/A
EX-4.3
ubeyrq4b075n4z3i2ly0
17 Jul 24
IPO registration (amended)
8:47am
S-1/A
EX-10.9
qdn3f1hzwh
17 Jul 24
IPO registration (amended)
8:47am
S-1
s4u islklm5z
3 Jul 24
IPO registration
6:29am
S-8
EX-5.1
ghr3a
20 Dec 23
Registration of securities for employees
5:05pm
8-K
fi4trcq55le50h
15 Dec 23
Changes in Registrant's Certifying Accountant
6:09am
8-K
EX-10.2
q5k495m
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-2.1
f9lu 0znfc5b
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-3.2
2puv2sprtcfjc hxv1z
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
6-K
EX-99.1
5w7z69fm d9o2odtj
8 Nov 23
Results of Scheme Meetings
6:07am
6-K
EX-99.1
echz41q6y4rcwlxkx5q5
10 Oct 23
Report of Foreign Private Issuer
6:15am